Iron deficiency in pulmonary arterial hypertension: perspectives - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Pulmonary circulation / Pulm Circ Année : 2021

Iron deficiency in pulmonary arterial hypertension: perspectives

Résumé

In left heart failure, iron supplementation (IS) is a first-line treatment option, regardless of anemia. Pulmonary arterial hypertension (PAH), a rare disease leading to right heart failure, is also associated with iron deficiency. While it is a much debated topic, recent evidence demonstrate that restoration of iron stores results in improved right ventricular function and exercise tolerance. Hence, IS may also be considered as an option in the treatment of PAH.
Fichier principal
Vignette du fichier
10.1177_20458940211021301.pdf (154.29 Ko) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

inserm-03934812 , version 1 (11-01-2023)

Identifiants

Citer

Marceau Quatredeniers, David Montani, Alain Cohen‐solal, Frédéric Perros. Iron deficiency in pulmonary arterial hypertension: perspectives. Pulmonary circulation / Pulm Circ, 2021, 11 (3), pp.20458940211021301. ⟨10.1177/20458940211021301⟩. ⟨inserm-03934812⟩
10 Consultations
25 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More